Blood thinner comparison after clot-busting for heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two blood-thinning medicines (bivalirudin vs. heparin) given during angioplasty to people who've already had a clot-buster for a heart attack. The goal is to see which one works better to keep arteries open without increasing bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack (STEMI) and received a clot-busting medicine within 12 hours of symptoms.
- You are scheduled to have a balloon angioplasty (PCI) within 24 hours of your first symptoms.
- You are taking the recommended combination of aspirin and another blood thinner (clopidogrel or ticagrelor) before your procedure.
- You do not have a serious heart complication (like a hole in the heart wall or shock) from the heart attack.
- You are not allergic to heparin, bivalirudin, aspirin, clopidogrel, or ticagrelor.
- You have not had a stent placed in the past 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether removing blood clots from blocked heart arteries during emergency treatment improves outcomes for patients having a major heart attack. You may qualify if you're having a heart attack with a large clot and are getting emergency intervention to open the artery.
This trial compares two blood thinners (bivalirudin and heparin) during a procedure to open blocked heart arteries (PCI) in patients with a recent heart attack or unstable angina who also have a high risk of bleeding. The goal is to see which drug works better and is safer for patients like you.
This study tests whether a blood thinner called bivalirudin, given during a procedure to open blocked heart arteries (PCI), helps blood flow better in the tiny vessels of the heart afterward. It is for people with a recent unstable heart condition and a high-risk plaque seen on a CT scan.
This trial tests whether giving a blood thinner (heparin) early, before you get to the hospital for a heart attack procedure, can improve outcomes. It is for people having a specific type of heart attack (STEMI) who will receive a balloon angioplasty within 2 hours.
This trial compares two ways to remove or break up a blood clot during emergency heart artery opening (primary PCI) for a specific type of heart attack (STEMI). It may help patients with a high clot burden by testing whether one approach works better than the other to improve outcomes.
This trial compares two common blood-thinning medications (prasugrel vs ticagrelor) and two treatment durations (short 1–3 months vs standard 12 months) after a heart attack treated with stents. It aims to find the most effective and safest anti-clotting strategy for patients.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.